Is Lonza Group AG (LZAGY) halal? Halal. Based on AAOIFI screening, Lonza Group AG passes both qualitative (business activity) and quantitative (financial ratio) screens with a compliance score of 85/100 (Grade: A).

Lonza Group AG

LZAGY: Is Lonza Group AG Halal?

Halal

Lonza Group AG

OTCHealthcareCH

$62.41

+1.00%

About Lonza Group AG

Lonza Group AG, along with its various affiliates, provides a comprehensive array of offerings for the pharmaceutical, biotechnology, and nutrition industries. Its global operations extend across Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and other international markets. The company's extensive activities are structured into four main divisions: Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients. The Biologics division specializes in the outsourced development and manufacturing of biopharmaceutical products. This encompasses both clinical and commercial production requirements, overseeing the entire product journey from initial drug substance creation to the final drug product formulation. The Small Molecules segment acts as an integrated service provider for the development and production of small molecule active pharmaceutical ingredients (APIs) and their intermediate compounds. It offers broad support to clients across all stages of design, advancement, and large-scale manufacturing. Lonza's Cell & Gene division is dedicated to developing innovative technologies and platforms that streamline and scale the manufacturing processes for cell and gene therapies. It also delivers expert contract development and manufacturing services, coupled with essential regulatory support, for a wide range of advanced treatments, including allogeneic and autologous cell therapies, exosome-based therapies, and viral vector gene therapies. Additionally, this segment supplies specialized raw materials and crucial technological solutions relevant to the cell and gene therapy, injectable drug, vaccine, and general bio-manufacturing sectors. The Capsules & Health Ingredients segment furnishes various encapsulation products, sophisticated dosage form solutions, and nutritional components to both pharmaceutical and nutraceutical customers. Founded in 1897, the company's primary corporate office is situated in Basel, Switzerland.

Sector: Healthcare · Industry: Medical - Diagnostics & Research

Shariah Compliance Status

معيار أيوفي 21تحديث ١١ يونيو ٢٠٢٦
A

Very Good

Strong compliance across all metrics

85Score

Business Activity Screen

Passed

Checks if the business is involved in prohibited activities (alcohol, gambling, pork, conventional banking, etc.)

Financial Ratio Screen

Passed

Financial ratios must be below AAOIFI thresholds

Debt / Market Cap12.2% / 30.0%

Compliance History

Halal, unchanged since Jun 2026.

No status changes recorded since we began tracking.

Tracked since Jun 2026. Updates automatically on each re-screen.

Screened: Jun 11, 2026Fiscal: FY 2025Source: FMP-ADR

Purify Your LZAGY Dividends

0.6% non-compliant income

LZAGY has 0.6% prohibited income. Calculate exactly how much of your dividends to donate.

Financial Overview

Market Cap

44.4B

Price

$62.41

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Free · No credit card required

Track LZAGY and 10,000+ stocks with AI insights

Create your free account to unlock AI-powered compliance analysis, track your portfolio, calculate purification, and get unlimited AAOIFI screening.

10,000+ assets AAOIFI standards Free watchlist

الأسئلة الشائعة

هل Lonza Group AG (LZAGY) حلال للاستثمار؟
Based on AAOIFI Standard 21 screening, Lonza Group AG (LZAGY) is rated Halal with a compliance grade of A (Very Good). It passes both the business activity screen (no primary involvement in prohibited sectors) and the quantitative financial ratio screen (debt, interest deposits, and prohibited income all below AAOIFI thresholds).
لماذا حصل Lonza Group AG على تقييم توافق A؟
Lonza Group AG (LZAGY) received a grade of A (Very Good) based on three AAOIFI Standard 21 financial ratios: debt-to-market-cap of 12.2% (limit 30%); interest-bearing deposits of 2.1% (limit 30%); prohibited income of 0.64% (limit 5%). The grade reflects the margin of safety across all three ratios relative to their thresholds.
ما الذي قد يغير حكم Lonza Group AG الشرعي؟
Lonza Group AG's verdict is re-evaluated at each annual re-screen. Three events could change it: (1) the debt-to-market-cap ratio crossing 30%, typically from new debt issuance or a major drop in share price; (2) interest-bearing deposits exceeding 30% of market cap; or (3) prohibited revenue (alcohol, gambling, conventional finance, etc.) exceeding 5% of total revenue. Verdict flips are tracked in the compliance history section above.
كم مرة يُعاد فحص Lonza Group AG للتوافق الشرعي؟
Lonza Group AG (LZAGY) is re-screened annually using the most recent full-year financial data from SEC filings. HalalScreener also triggers an on-demand re-screen whenever the stored data is more than 7 days old, ensuring the ratios reflect the latest available financial statements. Last screened: Jun 11, 2026.

مفحوص وفق معيار أيوفي رقم 21 · لأغراض إعلامية فقط. استشر مستشاراً مالياً إسلامياً مؤهلاً قبل الاستثمار.

Disclaimer: This screening is for informational purposes only and does not constitute financial, legal, or religious advice. Compliance is evaluated using AAOIFI financial standards (debt, deposits, and prohibited income ratios) and publicly available data. Ethical, political, social, or environmental considerations are outside the scope of this screening. Individual scholars and methodologies may differ. Always consult a qualified Islamic finance advisor before making investment decisions.